“I really enjoyed this cigar. Even though it was a bit one dimensional, it had very good flavors and it’s size made for a nice quick smoke. I would definitely smoke another one of these if I was given an opportunity.” –Alan (Eulogy)
The lawsuit filed jointly by IPCPR, CRA and CAA against the FDA will now be heard on August 30th, pushing the trial back from July 28th. The change was in response to the FDA’s original motion for a 60 day delay, in part to accommodate the transition from the Obama to Trump Administrations. The three trade associations agreed to the 30 day extension, however all three have made it clear to the federal government that any further delays would require extensions of pending compliance deadlines under the deeming rule.
Today President Trump announced Dr. Scott Gottlieb as his pick to lead the Food & Drug Administration (FDA). Dr. Gottlieb has an impressive and extensive resume, with a wide-ranging background in both the private and public sectors and a M.D. from Mount Sinai School of Medicine. IPCPR welcomes the pick of Dr. Gottlieb and, If confirmed, we look forward to working with him as we continue to advocate for common-sense reforms to the recent FDA regulation needlessly harming the family owned small businesses retailers that make up IPCPR.
Yesterday Congressman Bill Posey (R-FL) testified before the House Appropriations Subcommittee on Agriculture about the need for appropriations language exempting premium cigars from the FDA’s deeming rule. This testimony came during the Appropriations Committee’s annual members’ day. IPCPR applauds Congressman Posey and extends our thanks on behalf of premium cigar retailers and tobacconists across the country for his continued fight for premium cigars and individual liberty.